Potential neuroprotective effects of acamprosate

George F. Koob, Barbara J. Mason, Philippe De Witte, John Littleton, George R. Siggins

Research output: Contribution to journalArticlepeer-review

50 Scopus citations


This article represents the proceedings of a symposium at the 2001 RSA Meeting in Montreal, Canada. The organizers were Barbara J. Mason and George F. Koob. Anita M. Goodman served as chair. The presentations were (1) Acamprosate inhibits alcohol withdrawal-induced neurotoxicity in organotypic hippocampal cultures, by John Littleton; (2) Acamprosate alteration of NMDA receptor-dependent synaptic transmission and synaptic plasticity, by George R. Siggins; (3) Acamprosate and glutamate during ethanol withdrawal, by Philippe De Witte; (4) Clinical evidence of protective CNS effects of acamprosate in alcohol-dependent individuals, by Barbara J. Mason.

Original languageEnglish
Pages (from-to)586-592
Number of pages7
JournalAlcoholism: Clinical and Experimental Research
Issue number4
StatePublished - 2002


  • Acamprosate
  • Alcoholism
  • Glutamate
  • Neuroprotective

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Psychiatry and Mental health


Dive into the research topics of 'Potential neuroprotective effects of acamprosate'. Together they form a unique fingerprint.

Cite this